ASP2535

ASP2535 is an inhibitor of the type 1 glycine transporter. It could potentially be used in treatment of Alzheimer's disease and schizophrenia.

Potential uses

ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.